Stories about Chemie
- 4One documentmore
Press release: STADA and Xbrane launch ranibizumab to support patient access in Europe
STADA and Xbrane launch ranibizumab to support patient access in Europe - Ranibizumab biosimilar is being launched in major European markets - Ranibizumab is the first product brought to market through a strategic collaboration between STADA and Xbrane, marking Xbrane’s first commercial launch and ...
One documentmoreLAMILUX Composites at the transport logistic in Munich
One documentmore- 3
Press Release: SGL Carbon expands material portfolio with new carbon fiber for high-strength pressure vessels
One documentmore - 2
Press Release SGL Carbon to Supply Key Graphite Components for Wolfspeed Silicon Carbide Production Facilities
One documentmore - 4
Six Materials Nominated for the Innovation Award “Renewable Material of the Year 2023”
2 Documentsmore
- 4
RCI报告:碳流动–全球和欧洲经济中石化碳和可再生碳的供需
One documentmore - 4
RCI Carbon Flows Report: Compilation of supply and demand of fossil and renewable carbon on a global and European level
One documentmore - 5
From Emission-made Shoes to Jet Fuels – Smart Innovations Make CO₂ the Feedstock of the Future
One documentmore - 6
Bacteria-Based Cellulose Fibre NullarborTM (“No Trees“) Wins “Cellulose Fibre Innovation of the Year 2023” Award Against Strong Competition
One documentmore - 3
Press Release - hubergroup Print Solutions presents its one-stop portfolio for metal packaging at METPACK
One documentmore Press release: STADA sustains strong momentum with double-digit sales and profit growth in 2022
One documentmore
- 2
Press release: Expanding capacity: Aurubis invests € 120 million in expanding the tankhouse in Pirdop
One documentmore - 5
The Future Sustainable Chemical and Materials Industry will be Based Entirely on Recycling, Biomass and CO₂
One documentmore - 9
Gaining momentum – Bio-based polymers grow at a CAGR of 14% between 2022 and 2027
2 Documentsmore Press release: EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab) - Partners Alvotech and STADA have marketing authorization application (MAA) for ustekinumab accepted for filing by the European Medicines Agency (EMA) ...
One documentmore- 3
Press Release - hubergroup Chemicals debuts at the European Coatings Show
One documentmore - 4
Press Release - Sustainable commitment of hubergroup Deutschland awarded with EcoVadis silver medal
One documentmore
- 2
Analysis - Developer of mines with more than 200 projects
One documentmore Solid-state battery with salt instead of lithium - Interview
One documentmorePress Release SGL Carbon expands capacities for graphite products for use in the semiconductor industry
One documentmore- 2
Brenntag SE extends contract with Christian Kohlpaintner ahead of schedule
One documentmore - 4
Press release: Growth area of battery recycling: Aurubis starts test operation in new pilot plant in Hamburg
2 Documentsmore Brenntag enters the market in Israel with the acquisition of specialty chemicals expert Y.S. Ashkenazi Agencies
One documentmore
Innovation and Start-Up Center for Biotechnology (IZB) welcomes new start-up Origin.Bio
One documentmoreBrenntag announces new agreement with Corbion for Animal Nutrition in Belgium, The Netherlands and France
One documentmore- 2
Brenntag SE appoints Dr Kristin Neumann to the Management Board as CFO as of April 1, 2022
One documentmore Brenntag Specialties broadens its HI&I enzyme portfolio with the launch of the Perforzyme™ product line in North America
One documentmoreBrenntag’s Pharma section signs exclusive agreement for health-promoting product line Akovita ELIP in EMEA
One documentmoreBrenntag invests in its Animal Nutrition production unit in Kędzierzyn-Koźle, Poland
One documentmore
Previous1234Next